|
¡ÒÃà¾ÔèÁ¢Ö鹢ͧ¤ÇÒÁÇÔµ¶Òâͧ¼ÔÇ˹ѧ·Õè¼ÅÑ¡´Ñ¹µÅÒ´¡ÒúÃÃà·Ò·Ø¡¢ì´éÇÂáʧá»Åº»ÅÒº·ÑèÇâÅ¡
|
| - ¡ÒúӺѴ¾ÃéÍÁ´éÇÂáʧËÃ×ÍÇèÒ¡ÒéÒÂä¿à»ç¹»ÃÐàÀ·¡ÒÃÃÑ¡ÉÒáËè§Ë¹¼Ùé»èǵéͧÊÑÁ¼ÑʡѺáËÅ觡Óà¹Ô´áʧá»Åº»ÅÒºà·ÕÂÁÁռšÃзºÊÒÃà¤ÁÕã¹¢Áͧ·Õèà¡ÕèÂǡѺ¤ÇÒÁÃÙéÊÖ¡áÅЧҹ¹Í¹ËÅѺ´éÇ¡ѹÂѧÅØé¹ã¹¡ÒÃÃÕà«çµ¨Ñ§ËÇЧҹ¢Í§Ç§¨Ã«Ö觤Ǻ¤ØÁǧ¨Ã¡Òù͹¡ÒúӺѴµÃ§¹ÕéÁÑ¡ãªé㹡ÒôÓç¤ÇÒÁ¼Ô´»¡µÔ¡ÃÐÂÒàÅ ä´éá¡è ÀÒÇЫÖÁàÈÃéÒ·èǧ·èÒà¨çµÁͧç¡áÅФÇÒÁÇÔ»ÃÔµ¢Í§§Ò¹¹Í¹ËÅѺ¡ÒúӺѴ´éÇ»ÃСÒÂÂѧª´ãªé㹡ÒôÓçâä¨Ôµã¨µÒÁÄ´Ù¡ÒÅ (SAD) ÍÕ¡´éÇÂ
|
|
ÍèÒ¹¡ÅèÒÇÀÒ¾ÃÇÁ 13;
https://www.transparencymarketresearch.com/light-therapy-market.html
|
| - ÍѵÃÒà˵تءÊÔ觢ͧâä¼ÔÇ˹ѧ·ÕèÁÒ¡¢Öé¹ÃÇÁ¶Ö§¡ÒÃŧ·Ø¹ÍÂèÒ§µèÍà¹×èͧâ´Â¼Ùé¼ÅÔµà¾×èͨÐà»Ô´µÑǢͧãËÁè¡ÒÃàµÔºâµ¢Í§·éͧµÅÒ´àª×éÍà¾ÅÔ§¢Í§¼ÅÔµÀѳ±ìã¹¾ÃШѹ·Ãì¡ØÁÀҾѹ¸ì 2018 Clarify Medical ¤ÇéÒà»Ô´µÑÇÇÑÊ´ØÊèͧä¿á»Å¹ãªé´éÒÁ·Õèàª×èÍÁµè͡ѺÊÁÒÃì·â¿¹«Öè§ä´éÁÒ¡Òõé͹ÃѺ¨Ò¡Ë¹èǧҹÍÒËÒÃáÅÐÂҢͧÊËÃÑ°ÍàÁÃÔ¡ÒáËè§à´×͹ÁԶعÒ¹ 2017 ÍØ»¡Ã³ì¢Ñé¹ÊÙ§¹Õéãªé㹡ÒÃÃÑ¡ÉÒâä¼ÔÇ˹ѧàªè¹¤ÇÒÁà¨çºä¢éÊÐà¡ç´à§Ô¹âä´èÒ§¢ÒǡѺâäàÃ×é͹ÁÔ¤
|
µÑÇà´Ô¹à¤Ã×èͧÊÓ¤ÑáÅТéÍ ¡Ó˹´ ¢Í§·éͧµÅÒ´¡ÒúӺѴ¾ÃéÍÁ´éÇÂáʧ·ÑèÇâÅ¡
| | - ÀÒÃФÇÒÁ¼Ô´»¡µÔÁØ¢¼ÔÇ˹ѧ·Õèà¾ÔèÁ¢Öé¹ÃÇÁ·Ñé§ÊÔǼ´áÅÐâäÊÐà¡ç´à§Ô¹Ê¹ÑºÊ¹Ø¹¡ÒáéÒÇ˹éҢͧ·éͧµÅÒ´¨Ò¡º·¤ÇÒÁ·Õè¾ÔÁ¾ìã¹ Clinical, Cosmetic and Investigational Dermatology áËè§»Õ 2017 ¤ÇÒÁÇÔ»ÃÔµ¢Í§Ë¹Ñ§·ÕèÊÓ¤Ñ ä´éá¡è ¼ÔÇ˹ѧÍÑ¡àʺ / ¡ÅÒ¡ (31.5%), §Ò¹µÔ´àª×éÍäÇÃÑÊ (12.5%), ¤ÇÒÁ¼Ô´»¡µÔÊÃþÊÔè§àÁç´àªç´ (7.4%), melanocytic nevi (5.8%), alopecia areata(5.8%), ÊÔÇ (5.6%), ¤ÇÒÁ¼Ô´»¡µÔ¢Í§àÅçº (3.3%), ¤ÇÒÁ¼Ô´»¡µÔÊÔ觢ͧËÅÍ´âÅËÔµáÅÐ hemangiomas (2.9%), âäÀÑÂä¢éà¨çºÊÐà¡ç´à§Ô¹ (2.6%) áÅСÒõԴàª×éͺѡàµÃÕ (2.6%)à¹×èͧ¨Ò¡¡ÒÃÃÑ¡ÉÒ·ÕèÁÕ»ÃÐÊÔ·¸ÔÀÒ¾ÊÙ§ÈÑ¡´ÔìÊÓËÃѺâä¼ÔÇ˹ѧËÅÒª¹Ô´ÃÇÁ¶Ö§¤ÇÒÁà¨çº»èÇÂÊÐà¡ç´à§Ô¹âä´èÒ§¢ÒÇâä¼ÔÇ˹ѧÍÑ¡àʺáÅÐâä¼ÔÇ˹ѧÍ×è¹ æ ¤Ò´´ØµÅÒ´¡ÒúÃÃà·Ò·Ø¡¢ì´éÇÂáʧáǺ¨Ð¡éÒÇ˹éÒ¢Öé¹
| ¢ÍâºÃªÑÇÃì·ÙÅ 13;
https://www.transparencymarketresearch.com/sample/sampleÁѹÊÁͧphp?flag=B&rep_id=73923
| | - ¹âºÒ¡Òä׹ÊÁºÑµÔ·Õè´Õã¹»ÃÐà·Èʶҹ·Õè¾Ñ²¹ÒáÅéǨЪèÇ¡ÃеØ鹧ҹàµÔºâµ¢Í§·éͧµÅÒ´µèÍ仡ÒúӺѴ´éÇÂáʧÁÕÊÔ·¸Ôìä´éÃѺ¡ÒêÓÃÐà§Ô¹¡ÅѺ¤×¹´éǺѪէҹãªé¨èÒ·Õè¼è͹¼Ñ¹ (FSA) ºÑªÕÍÍÁ·ÃѾÂìà¾×èÍÊØ¢ÀÒ¾ (HSA) ËÃ×Í¡ÒèѴ¡ÒáÒêÓÃÐà§Ô¹¤×¹Í¹ÒÁÑ (HRA)
| - ¼Å¢éÒ§à¤Õ§¢Í§¡ÒÃàÂÕÂÇÂÒÃÑ¡ÉÒ´éÇÂáʧ à»ç¹µé¹ÇèÒ »Ç´ÈÕÃÉÐáʺÃé͹¹Ñ¹ìµÒ»Ç´¤Ñ¹áÅФÅ×è¹äÊé»Ñ¨¨Ñ¹ÕéÍÒ¨¨Ð¢Ñ´¢ÇÒ§¡ÒÃàµÔºâµ¢Í§µÅÒ´¡ÒÃàÂÕÂÇÂÒ´éÇÂáʧÀÒÂÀҤ˹éÒÍѹã¡Åé
|
| ÍØ»¡Ã³ì¾¡¾Òà¾×èÍ¡ÒÃÃÑ¡ÉÒ¼ÔÇ˹ѧáËè§ÁÕ¤ÇÒÁµéͧ¡ÒÃÊÙ§ÈÑ¡´Ôì
|
| - µÒÁ»ÃÐàÀ·¼ÅÔµÀѳ±ìµÅÒ´¡ÒúӺѴ´éÇÂáʧ·ÑèÇâÅ¡ÊÒÁÒö¨ÓṡÍÍ¡à»ç¹¡ÅÑ¡ä¿â¤Áä¿´ÅáÅÐâ¤Á俵Ñé§âµêзÕè¡Ñ¹áʧÍØ»¡Ã³ì´éÒÁÊÓËÃѺ¡ÒÃÃÑ¡ÉÒ¼ÔÇ˹ѧ (HDST) à¤Ã×èͧ¨ÓÅͧÃØè§á¨é§ËÅʹ俺ӺѴ¡ÑºÍ×è¹ æ
| - ÍØ»¡Ã³ì¾¡¾ÒÊÓËÃѺ¡ÒÃÃÑ¡ÉÒ˹ѧ (HDST) ¶×ͤÃͧÊèǹáºè§ËÅѡࢵ¢Í§µÅÒ´¡ÒÃàÂÕÂÇÂÒ´éÇÂáʧ·ÑèÇâÅ¡´éÇ¡ѹ¤Ò´ÇèҨѡàµÔºâµ¢Öé¹¢¹Ò¹ãËè㹪èǧàÇÅÒ¤Ò´¡ÒóìÅèǧ˹éÒAllure ä´éÃѺà¤Ã×èͧÁ×ÍÊÍ´Êèͧ´ÙáżÔǨҡ¹ÒÂá¾·Âì¼ÔÇ˹ѧáÅÐáËè§ä´éÃѺ¡ÒÃÃѺÃͧ¨Ò¡ºÃóҸԡÒó»Õ 2019 ÃÇÁ¶Ö§¡ÐËÁÍ¡ LED Ẻ¾¡¾Ò·Õè¤ÃèÒÃÔéÇÃ͵ÒÁªèǧàÇÅÒ
| - «Õ¡·ÕèºÑ§ÊÐà¡ç´ä¿¤Ò´ÇèҨТÂÒµÑÇ·Õè CAGR áËè§ÊÓ¤Ñ㹪èǧàÇÅÒ¤Ò´¡Òóì¡ÒÃÂÔ¹ÂÍÁ¾ÃéÍÁã¨ÍØ»¡Ã³ìÅ´¹éÓ˹ѡÃèÒ§¾¡¾Òàªè¹·Õ袹ѹáʧà¾×èÍ¡ÒèѴ¡ÒüÙé»èÇÂáËè§ÁÕ»ÃÐÊÔ·¸ÔÀÒ¾¨ÐªèÇÂàÃ觡ÒÃàµÔºâµÊÃþÊÔ觡ÅØèÁã¹Í¹Ò¤µÊÔè§ã¡Åé¹Õé
|
|
¤Ó¢ÍÇÔà¤ÃÒÐËì¼Å¡ÃзºÊÃþÊÔè§ COVID-19 µèÍ¡ÒúӺѴÍÕ¡´éÇÂáʧµÅÒ´ 13;
https://wwwÁѹÊÁͧtransparencymarketresearchÁѹÊÁͧcom/sample/sample.php?flag=covid19&rep_id=73923
| ËÁÇ´»ÃСÒÂàÅ×Í´¹¡à¾×èͤÃͺ¤ÃͧÊÑ¡¢Õ¾Âҹ㹧ҹà¨ÃÔÊÙ§ÊØ´
ÃÑ¡ÉÒÊÔÇ
|
| - µÒÁª¹Ô´ÊÔ觢ͧáʧµÅÒ´¡ÒúÃÃà·Ò·Ø¡¢ì¾ÃéÍÁ´éÇÂáʧáǺ·ÑèÇâÅ¡ÊÒÁÒöáºè§ãËé¡Óà¹Ô´à»ç¹áʧáǺ¶Ù¹ÀÒÅÑÂáʧàÅ×Í´¹¡ÊÐà¡ç´ä¿¶Ù¢ÒÇ´éÇ¡ѹÍ×è¹ æ (ÊÐà¡ç´ä¿ÊÕà¢ÕÂÇ´éÇ¡ѹ»ÃСÒÂä¿ÊÕàËÅ×ͧ)
| - ¤ÃÒÁ¡ÅØèÁ»ÃСÒÂ俤ÃͧµÅÒ´¡ÒúӺѴ¾ÃéÍÁ´éÇ»ÃСÒ·ÑèÇâÅ¡ã¹·ÕèªÑ¹ÉÒ 2018 §Ò¹ãªé¤×¹ÊÐà¡ç´ä¿ÊÕ¿Ò¡¿éÒ㹡ÒôÓçÀÒÇ¡Òóì´éÇ¡ѹ¤ÇÒÁ¼Ô´»¡µÔ·Ò§¡ÒÃá¾·ÂìµèÒ§æàªè¹âäÀÑ·ÕèÁÕ»ÃÐÊÔ·¸Ô¼ÅµÒÁÄ´Ù¡ÒÅ (SAD) ÊÔǼ×è¹à»ç¹ÍÒ·ÔÁÕá¹Çâ¹éÁ·Õè¨ÐÁÒ¡¢Ö鹧ҹ¡éÒÇ˹éҢͧËÁÇ´¤ÇÒÁÁØè§ÁÒ´¡ÒÃàÂÕÂÇÂÒ´éÇÂÊÐà¡ç´ä¿ÊÕ¡ÅÒ§ËÒÇ·Õèà¾ÔèÁ¢Öé¹ã¹·Õè¡ÒÃÃÑ¡ÉÒâä¼ÔÇ˹ѧµèÒ§æ¨ÐÅØé¹à´Ô¹à¤Ã×èͧ«Õ¡¹Õé¶Ñ´ä»
| - »ÃСÒÂ俪Ҵ¤Ò´ÇèҨФÃͺ¤ÃͧÊèǹáËè§à¨ÃÔÍÂèÒ§àÃçÇã¹·ÕèªèǧàÇÅÒ¾Âҡóìà¹×èͧ¨Ò¡§Ò¹ÂÍÁÃѺ¡ÒÃàÂÕÂÇÂÒÃÑ¡ÉÒ´éÇÂÊÐà¡ç´ä¿ÊÕá´§ÍÂèÒ§¡ÇéÒ§¢ÇÒ§áË觡ÒôÓçµèÒ§æáË觾ÃÃÉÒ 2019 ¡§ÊÕ PhotonMD, Inc. ä´é¢éÍÁÙżÅÊÃØ»àªÔ§ºÇ¡¨Ò¡¡Ò÷´Åͧ·Ò§¤ÅÔ¹Ô¡áËè§ÊӤѫÖ觻ÃÐàÁÔ¹¡ÅØèÁÇÑÊ´ØÊÃéÒ§¼ÁËÁÒÂÃÇÁ REVIAN RED à¾ÃÒдéÇ¡ÒÃÃÑ¡ÉÒ¢éÒ¾à¨éÒµ¡µé¹©ºÑºá͹â´Ãਹ㹡Ò÷´Åͧª´ãªé REVIAN RED ¤ÇéÒáÊ´§ãËéàË繶֧¤ÇÒÁÊÒÁÒö³¡ÒÃËÂØ´¢éÒ¾à¨éÒµ¡´éÇ¡ѹ»ÅÙ¡ÊÃéÒ§¢éÒ¾à¨éÒãËÁè¤ÇéÒÊÓàÃç¨
|
|
ÍàÁÃÔ¡Òà˹×ͤÃͧµÅÒ´¡ÒÃàÂÕÂÇÂÒ¾ÃéÍÁ´éÇ»ÃСÒ·ÑèÇâÅ¡
p> | | - ã¹á§èÊÃþÊÔè§ÀÒ¤·éͧµÅÒ´¡ÒÃàÂÕÂÇÂÒÃÑ¡ÉÒÍÕ¡´éÇÂÊÐà¡ç´ä¿·ÑèÇâÅ¡ÊÒÁÒöá¡ÍÍ¡´Óç°Ò¹Ð»ÃÐà·ÈÊËÃÑ°ÍàÁÃԡҹ͡à˹×ÍÂØâûàÍàªÕÂừԿԡÅеԹÍàÁÃÔ¡ÒµÐÇѹÍÍ¡¡ÅÒ§¡Ñº·ÇÕ»ÍÒ¿ÃÔ¡Ò
| - »ÃÐà·ÈÊËÃÑ°ÍàÁÃÔ¡Òà˹×ͤÃͧµÅÒ´¡ÒÃÃÑ¡ÉÒÍÕ¡´éÇ»ÃСÒÂä¿·ÑèÇâš㹪ѹÉÒ 2018 ¤ÇÒÁªØÁÊÃþÊÔ觤ÇÒÁÇÔ»ÃÔµ¢Í§Ë¹Ñ§ÃÇÁ¶Ö§âäàÃ×é͹ÁÔ¤´éÇ¡ѹÁÐàÃ秼ÔÇ˹ѧ㹷ÕèÍàÁÃÔ¡Òà˹×Í¡ÓÅѧ¡Ò´ѹ·éͧµÅÒ´¡ÒÃÃÑ¡ÉÒàªè¹¡Ñ¹áʧ¢¹Á¨Ò¡¡ÒÃÈÖ¡ÉÒàÅèÒàÃÕ¹áË觪èǧ»Ñ¨¨ØºÑ¹ÊÃþÊÔè§ÁÙŹԸÔâäÀÑÂä¢éà¨çºÊÐà¡ç´à§Ô¹áË觪ҵÔÊËÃÑ°ÍàÁÃÔ¡Ò¤¹ÍàÁÃԡѹÁÒ¡¡ÇèÒ 8 àÅÕè¹Á¹ØÉÂìà»ç¹âäÊÐà¡ç´à§Ô¹µÒÁ American Academy of Dermatology (AAD) ÊÔÇ´Óç°Ò¹ÐʶҹÐÇÃóÐáËè§Ë¹¾ºà»ç¹¹ÔµÂìÊØ´âµè§ã¹·ÕèÍàÁÃÔ¡Ò«Öè§Ê觼šÃзº´ÒÁ¤¹ÍàÁÃԡѹÂÔ觹ѡ¨Ã´ 50 ¡Åé͹¤¹·Òº¾ÃÃÉÒ¡ÒÃŧ·Ø¹·Õè·ÇÕ¨Ò¡ÀÒ¤ÃÑ°ºÒÅáÅÐ˹èǧҹµèÒ§æ¤Ò´¤Ð๴بѡÊè§àÊÃÔÁ·éͧµÅÒ´¡ÒúÃÃà·Ò·Ø¡¢ìÍÕ¡´éÇÂÊÐà¡ç´ä¿ã¹»ÃÐà·ÈÊËÃÑ°ÍàÁÃÔ¡Òà˹×Í
| - ¡ÒÃÃѺÃÙé¾ÃéÍÁ´éÇÂÀÒÃÐÊÃþÊÔè§âä·Õèà¾ÔèÁ¢Öé¹à»ç¹»Ñ¨¨Ñºҧ»ÃСÒÃʶҹ·Õè¤Ò´µÇÒ´¨Ðà´Ô¹à¤Ã×èͧµÅÒ´¡ÒÃàÂÕÂÇÂÒÃÑ¡ÉÒ´éÇ»ÃСÒÂä¿ã¹·ÇÕ»àÍàªÕÂừԿԡµÅÒ´à¡Ô´¹ÇªÒµàªè¹»ÃÐà·È¨Õ¹áÅÐÍÔ¹à´ÕÂÁÕâÍ¡ÒÊ¡éÒÇ˹éÒÊÙ§ÊÓËÃѺ¼ÙéàÅè¹ã¹µÅÒ´¢éͤÇÒÁªØ¡ÊÃþÊÔè§âäÊÐà¡ç´à§Ô¹ã¹»ÃÐà·ÈàÁ×ͧ¨Õ¹ÍÂÙèÃÐËÇèÒ§ 0.11% ¶Ö§ 0.47% µÒÁ¡ÒÃËÒ¤ÇÒÁÃÙé·Õè¾ÔÁ¾ìàÃ×èͧÃкҴÇÔ·ÂÒáÅСÒÃÃÑ¡ÉÒâäÀÑÂä¢éà¨çºÊÐà¡ç´à§Ô¹: ÁØÁÁͧ¢Í§¨Õ¹ã¹·Õè»Õ 2014
|
| Pre Book¡ÅèÒǵÅÒ´ºÓºÑ´´éÇ»ÃСÒ 13;
https://www.transparencymarketresearchÁѹÊÁͧcom/checkout.php?rep_id=73923<ype=S
| ¼Ùé¡èÍ¡Óà¹Ô´ÃÒÂÊÓ¤ÑáËè§Ë¹´Óà¹Ô¹¡Ô¨¸ØÃÐã¹µÅÒ´âÅ¡
| µÅÒ´¡ÒúӺѴÍÕ¡´éÇÂáʧ·ÑèÇâÅ¡ÁÕ¡ÒÃá¡ÃèÒ§ÍÂèÒ§ÁÒ¡·Õè»Õ 2018 ¼ÙéÊÃéÒ§ÃÒÂÊӤѷÕè´Óà¹Ô¹¡Ô¨¸ØÃÐã¹µÅÒ´âÅ¡ à»ç¹µé¹ÇèÒ :
| | - Northern Light Technologies
| - Verilux, Inc
|- Koninklijke Philips NV
|- Beurer
|- AuraDayLight
|- NATUREBRIGHT
|- Carex
|- Lucimed SA
| - Lumie
| - Sphere Gadget Technologies
|
| à¡ÕèÂǡѺàÃÒ
| ¡ÒÃÇԨѵÅÒ´à¾×èͤÇÒÁâ»Ãè§ãʤÃͺ¤Ãͧ ºÃÔÉÑ· ¢èÒÇ¡Ãͧ´éÒ¹¡ÒõÅÒ´ÃдѺâšʶҹ·ÕèãËéºÃÔ¡ÒÃÃÒ§ҹ¢èÒÇÊÒøØáԨ·ÑèÇâÅ¡§Ò¹¼ÊÁ¼ÊÒ¹ÃÐËÇèÒ§§Ò¹¾ÂҡóìªÒ»ÃÔÁÒ³áÅСÒþԹԨ¾Ô¨ÒóÒá¹Çâ¹éÁáËè§Ë¹à»ç¹àÍ¡ÊÔ·¸Ôì੾ÒÐÊÔ觢ͧàÃÒÅØé¹ãËéà¨éÒ¹ÒµѴÊÔ¹ã¨ÁÒ¡¤¹¨éͧ仢éҧ˹éÒ·ÕÁ¹Ñ¡ÇÔà¤ÃÒÐËì¹Ñ¡ÇÔ¨ÑÂáÅзÕè»ÃÖ¡ÉÒ·ÕèÁÕ»ÃÐʺ¡ÒóìÊÃþÊÔè§àÃÒãªé¤×¹áËÅ觢éÍÁÙÅ·Õèà»ç¹¡ÃÃÁÊÔ·¸ÔìáÅÐà¤Ã×èͧÁ×Í´éÇ¡ѹ෤¹Ô¤¡ÃÐÂÒàÅÂ㹡ÒÃÃǺÃÇÁ´éÇ¡ѹÇÔà¤ÃÒÐËì¢èÒÇÊÒÃ
| ·Õèà¡çº¢èÒÇÊÒâͧ´Ô©Ñ¹ä´éÃѺ§Ò¹ÍѻവáÅÐàÂÕÂÇÂÒÍÂèÒ§µèÍà¹×èͧâ´Â¤³Ð¼ÙéàªÕèÂǪһա¡ÒÃÇԨѾÍãËéÊзé͹¨Ã´á¹Çâ¹éÁáÅТéÍÁÙÅÅèÒÊØ´àÊÁÍàªè¹¡Ñ¹¤ÇÒÁÊÒÁÒö·Õè¡ÒÃÇԨѡѺÇÔà¤ÃÒÐËì·Õè¡ÇéÒ§¢ÇÒ§ Transparency Market Research ª´ãªéà·¤¹Ô¤§Ò¹¤é¹¤ÇéÒÇÔ¨ÑÂËÅÑ¡¡ÑºÃͧáËè§à¢éÁ§Ç´áË觡ÒþѲ¹ÒªØ´»ÃСÒÈ·ÕèÊдشµÒáÅÐàÍ¡ÊÒáÒÃÇÔ¨ÑÂà¾ÃÒÐÃÒ§ҹ·Ò§¸ØáԨ